These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 24973441)

  • 1. Dendritic cells and anergic type I NKT cells play a crucial role in sulfatide-mediated immune regulation in experimental autoimmune encephalomyelitis.
    Maricic I; Halder R; Bischof F; Kumar V
    J Immunol; 2014 Aug; 193(3):1035-46. PubMed ID: 24973441
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sulfatide administration leads to inhibition of HIV-1 replication and enhanced hematopoeisis.
    Sundell IB; Halder R; Zhang M; Maricic I; Koka PS; Kumar V
    J Stem Cells; 2010; 5(1):33-42. PubMed ID: 20861926
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Type II NKT cell-mediated anergy induction in type I NKT cells prevents inflammatory liver disease.
    Halder RC; Aguilera C; Maricic I; Kumar V
    J Clin Invest; 2007 Aug; 117(8):2302-12. PubMed ID: 17641782
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sulfatide-activated type II NKT cells suppress immunogenic maturation of lung dendritic cells in murine models of asthma.
    Pan H; Zhang G; Nie H; Li S; He S; Yang J
    Am J Physiol Lung Cell Mol Physiol; 2019 Nov; 317(5):L578-L590. PubMed ID: 31432714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sulfatide inhibits α-galactosylceramide presentation by dendritic cells.
    Kanamori M; Tasumi Y; Iyoda T; Ushida M; Inaba K
    Int Immunol; 2012 Feb; 24(2):129-36. PubMed ID: 22247226
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiple tissue-specific isoforms of sulfatide activate CD1d-restricted type II NKT cells.
    Blomqvist M; Rhost S; Teneberg S; Löfbom L; Osterbye T; Brigl M; Månsson JE; Cardell SL
    Eur J Immunol; 2009 Jul; 39(7):1726-35. PubMed ID: 19582739
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention of autoimmunity by targeting a distinct, noninvariant CD1d-reactive T cell population reactive to sulfatide.
    Jahng A; Maricic I; Aguilera C; Cardell S; Halder RC; Kumar V
    J Exp Med; 2004 Apr; 199(7):947-57. PubMed ID: 15051763
    [TBL] [Abstract][Full Text] [Related]  

  • 8. B7-H1-deficiency enhances the potential of tolerogenic dendritic cells by activating CD1d-restricted type II NKT cells.
    Brandl C; Ortler S; Herrmann T; Cardell S; Lutz MB; Wiendl H
    PLoS One; 2010 May; 5(5):e10800. PubMed ID: 20520738
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sulfatide-mediated activation of type II natural killer T cells prevents hepatic ischemic reperfusion injury in mice.
    Arrenberg P; Maricic I; Kumar V
    Gastroenterology; 2011 Feb; 140(2):646-55. PubMed ID: 20950612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of type I natural killer T cells by retinoids or following sulfatide-mediated activation of type II natural killer T cells attenuates alcoholic liver disease in mice.
    Maricic I; Sheng H; Marrero I; Seki E; Kisseleva T; Chaturvedi S; Molle N; Mathews SA; Gao B; Kumar V
    Hepatology; 2015 Apr; 61(4):1357-69. PubMed ID: 25477000
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recognition of lysophosphatidylcholine by type II NKT cells and protection from an inflammatory liver disease.
    Maricic I; Girardi E; Zajonc DM; Kumar V
    J Immunol; 2014 Nov; 193(9):4580-9. PubMed ID: 25261475
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distinct pathological patterns in relapsing-remitting and chronic models of experimental autoimmune enchephalomyelitis and the neuroprotective effect of glatiramer acetate.
    Aharoni R; Vainshtein A; Stock A; Eilam R; From R; Shinder V; Arnon R
    J Autoimmun; 2011 Nov; 37(3):228-41. PubMed ID: 21752599
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activated invariant NKT cells control central nervous system autoimmunity in a mechanism that involves myeloid-derived suppressor cells.
    Parekh VV; Wu L; Olivares-Villagómez D; Wilson KT; Van Kaer L
    J Immunol; 2013 Mar; 190(5):1948-60. PubMed ID: 23345328
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NKT cells can help mediate the protective effects of 1,25-dihydroxyvitamin D3 in experimental autoimmune encephalomyelitis in mice.
    Waddell A; Zhao J; Cantorna MT
    Int Immunol; 2015 May; 27(5):237-44. PubMed ID: 25574039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interdependency of MHC class II/self-peptide and CD1d/self-glycolipid presentation by TNF-matured dendritic cells for protection from autoimmunity.
    Wiethe C; Schiemann M; Busch D; Haeberle L; Kopf M; Schuler G; Lutz MB
    J Immunol; 2007 Apr; 178(8):4908-16. PubMed ID: 17404272
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of dendritic cell properties by laquinimod as a mechanism for modulating multiple sclerosis.
    Jolivel V; Luessi F; Masri J; Kraus SH; Hubo M; Poisa-Beiro L; Klebow S; Paterka M; Yogev N; Tumani H; Furlan R; Siffrin V; Jonuleit H; Zipp F; Waisman A
    Brain; 2013 Apr; 136(Pt 4):1048-66. PubMed ID: 23518712
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of novel glycolipid ligands activating a sulfatide-reactive, CD1d-restricted, type II natural killer T lymphocyte.
    Rhost S; Löfbom L; Rynmark BM; Pei B; Månsson JE; Teneberg S; Blomqvist M; Cardell SL
    Eur J Immunol; 2012 Nov; 42(11):2851-60. PubMed ID: 22777932
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sulfatide, a major lipid component of myelin sheath, activates inflammatory responses as an endogenous stimulator in brain-resident immune cells.
    Jeon SB; Yoon HJ; Park SH; Kim IH; Park EJ
    J Immunol; 2008 Dec; 181(11):8077-87. PubMed ID: 19018000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sulfatide-activated type II NKT cells prevent allergic airway inflammation by inhibiting type I NKT cell function in a mouse model of asthma.
    Zhang G; Nie H; Yang J; Ding X; Huang Y; Yu H; Li R; Yuan Z; Hu S
    Am J Physiol Lung Cell Mol Physiol; 2011 Dec; 301(6):L975-84. PubMed ID: 21856813
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathologic role and temporal appearance of newly emerging autoepitopes in relapsing experimental autoimmune encephalomyelitis.
    Vanderlugt CL; Neville KL; Nikcevich KM; Eagar TN; Bluestone JA; Miller SD
    J Immunol; 2000 Jan; 164(2):670-8. PubMed ID: 10623809
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.